A major Australian newspaper is questioning why the country’s regulatory agency for drugs and medical devices allowed DePuy’s all-metal hip implants to be sold there for years after data showed they had a high early failure rate.
The report in the Sydney Morning Herald mentions documents the New York Times obtained through the Freedom of Information Act, which indicated that DePuy executives sold the devices in the United States and abroad despite knowing that they were potentially dangerous for patients who ...
continue reading...